Sichuan Kelun Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Sichuan Kelun Pharmaceutical has a total shareholder equity of CN¥25.9B and total debt of CN¥5.1B, which brings its debt-to-equity ratio to 19.7%. Its total assets and total liabilities are CN¥37.7B and CN¥11.8B respectively. Sichuan Kelun Pharmaceutical's EBIT is CN¥3.7B making its interest coverage ratio -18.1. It has cash and short-term investments of CN¥6.8B.
Key information
19.7%
Debt to equity ratio
CN¥5.09b
Debt
| Interest coverage ratio | -18.1x |
| Cash | CN¥6.83b |
| Equity | CN¥25.87b |
| Total liabilities | CN¥11.80b |
| Total assets | CN¥37.68b |
Recent financial health updates
These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely
Feb 27
Recent updates
If EPS Growth Is Important To You, Sichuan Kelun Pharmaceutical (SZSE:002422) Presents An Opportunity
Mar 19Sichuan Kelun Pharmaceutical Co., Ltd. (SZSE:002422) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Mar 04These 4 Measures Indicate That Sichuan Kelun Pharmaceutical (SZSE:002422) Is Using Debt Safely
Feb 27Financial Position Analysis
Short Term Liabilities: 002422's short term assets (CN¥19.2B) exceed its short term liabilities (CN¥9.7B).
Long Term Liabilities: 002422's short term assets (CN¥19.2B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 002422 has more cash than its total debt.
Reducing Debt: 002422's debt to equity ratio has reduced from 85.7% to 19.7% over the past 5 years.
Debt Coverage: 002422's debt is well covered by operating cash flow (100.4%).
Interest Coverage: 002422 earns more interest than it pays, so coverage of interest payments is not a concern.